However, haplotype analyses indicated that a two-SNP core haplotype (SNP4-5, AA) in AKT1 was associated with a significantly increased susceptibility to NPC risk (adjusted OR  =  3.87, 95% CI  =  1.96–7.65; P<0.001). The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.